A Breath Of Hope Lung Foundation
- Assets
- $1.2m
- Revenue
- $1.2m
- Investments
- $0.0
- Employees
- 10
- Location
- Wayzata, MN
- Founding
- 12/2008
- Data as of
- 12/2021
- EIN
- 30-0475578
Organization Overview
A Breath Of Hope Lung Foundation is located in Wayzata, MN. The organization was established in 2008. According to its NTEE Classification (G12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 12/2021, A Breath Of Hope Lung Foundation employed 10 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. A Breath Of Hope Lung Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, A Breath Of Hope Lung Foundation generated $1.2m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 16.4% each year . All expenses for the organization totaled $933.0k during the year ending 12/2021. While expenses have increased by 11.3% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2018, A Breath Of Hope Lung Foundation has awarded 13 individual grants totaling $750,000. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
A BREATH OF HOPE LUNG FOUNDATION FIGHTS LUNG CANCER BY FUNDING INNOVATIVE U.S. RESEARCH, RAISING AWARENESS AND SUPPORTING PATIENTS AND FAMILIES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCH PROGRAM: PER CANCER DEATH AND ITS BURDEN ON SOCIETY, LUNG CANCER RESEARCH IS GREATLY UNDERFUNDED. A BREATH OF HOPE LUNG FOUNDATION (ABOH) HAS INVESTED WELL OVER $1 MILLION DOLLARS THROUGH COMPETITIVE $150,000 AWARDS THAT SUPPORT RESEARCH PROJECTS AT U.S. RESEARCH INSTITUTIONS. ABOH'S FOCUS HAS BEEN SUPPORTING YOUNG INVESTIGATORS TO IMPROVE THE RETENTION OF THE TOP TALENT IN THIS PARTICULAR CANCER FIELD. FUNDED RESEARCH PROJECTS ARE CAREFULLY VETTED BY A TEAM OF EXPERTS, BOTH NATIONALLY AND LOCALLY. WE ARE PROUD TO SUPPORT SOME OF THE MOST IMPORTANT TRANSLATIONAL LUNG CANCER RESEARCH IN THE NATION. ABOH RECEIVES ITS RESEARCH SUPPORT MOSTLY FROM INDIVIDUAL DONORS AND FAMILIES WHO ARE LIVING WITH LUNG CANCER OR HAVE ENDURED THE LOSS OF A LOVED ONE TO LUNG CANCER.
WHITE RIBBON AWARENESS PROGRAM (WRAP): BETWEEN 70-80,000 NONSMOKING AMERICANS DIE EACH YEAR. APPROXIMATELY 20% OF ALL CANCER DEATHS HAPPEN TO NEVER-SMOKERS (DEFINED AS HAVING SMOKED LESS THAN 100 CIGARETTES IN THEIR LIFETIME). DESPITE THESE PUBLISHED STATISTICS, MANY IN THE PUBLIC REALM BELIEVE THAT SMOKING IS THE ONLY CAUSE OF LUNG CANCER WHICH CAN LEAD TO MISSED SYMPTOMS AND LATE-STAGE DIAGNOSES. THERE ARE MANY CAUSES OF LUNG CANCER, FROM GENETIC PREDISPOSITION TO FAMILY HISTORY, RADON, AND ASBESTOS EXPOSURE TO AIR QUALITY IN GENERAL. APPROXIMATELY 70% OF LUNG CANCER PATIENTS ARE DIAGNOSED AT STAGE 3 OR 4 - WHEN IT IS DIFFICULT TO TREAT. ABOH REACHES 1,000,000 OR MORE PEOPLE EACH YEAR WITH LIFE-SAVING MESSAGES FOCUSED ON EARLIER DETECTION OF LUNG CANCER THROUGH BILLBOARD CAMPAIGNS, ONLINE MARKETING, SOCIAL MEDIA, PUBLIC PRESENTATIONS AND AWARENESS PROGRAM EVENTS.
PATIENT & FAMILY SUPPORT PROGRAMS: THE SMOKING STIGMA, SOCIETAL BLAME AND POOR PROGNOSIS OF LUNG CANCER LEAD TO HIGH LEVELS OF ANXIETY AND SORROW FOR THOSE WHO ARE LIVING WITH LUNG CANCER, WHETHER THEY SMOKED OR NOT. AN INFORMED, WELL-EDUCATED AND SUPPORTED PATIENT CAN PARTICIPATE IN SHARED DECISION-MAKING WITH HIS OR HER DOCTOR, AND THIS HAS BEEN SHOWN TO PRODUCE IMPROVED HEALTH OUTCOMES. ABOH IS HOSTING THE FIRST OF ITS KIND ONLINE, ANIMATED PATIENT EDUCATION PROGRAM AT WWW.YOUANDLUNGCANCER.COM, ALSO AVAILABLE IN SPANISH AT WWW.USTEDYCANCERDEPULMON.COM. THE BEAUTY OF THIS PROGRAM IS ITS ABILITY TO OVERCOME BARRIERS OF EDUCATION AND MEDICAL ILLITERACY TO EDUCATE LUNG CANCER PATIENTS AND THEIR FAMILY MEMBERS - NO MATTER THEIR LEARNING STYLE. ANOTHER COMPONENT OF ABOH'S SUPPORT PROGRAMS IS ITS AMBASSADOR PROGRAM, WHICH PROVIDES TRANSPORTATION, COMPANIONSHIP VISITS, AND SUPPORT GROUPS FOR PATIENTS, AS WELL AS AN ANNUAL PATIENT SUMMIT WITH HIGH-LEVEL EDUCATION DIRECTED AT PATIENTS AND CAREGIVERS LIVING WITH LUNG CANCER. ABOH IS ALSO HOSTING A LOCAL, QUARTERLY GRIEF GROUP FOR FAMILIES WHO HAVE LOST A LOVED ONE TO LUNG CANCER.
RESEARCH PROGRAM: PER CANCER DEATH AND ITS BURDEN ON SOCIETY, LUNG CANCER RESEARCH IS GREATLY UNDERFUNDED. A BREATH OF HOPE LUNG FOUNDATION (ABOH) HAS INVESTED WELL OVER $1 MILLION DOLLARS THROUGH COMPETITIVE $150,000 AWARDS THAT SUPPORT RESEARCH PROJECTS AT U.S. RESEARCH INSTITUTIONS. ABOH'S FOCUS HAS BEEN SUPPORTING YOUNG INVESTIGATORS TO IMPROVE THE RETENTION OF THE TOP TALENT IN THIS PARTICULAR CANCER FIELD. FUNDED RESEARCH PROJECTS ARE CAREFULLY VETTED BY A TEAM OF EXPERTS, BOTH NATIONALLY AND LOCALLY. WE ARE PROUD TO SUPPORT SOME OF THE MOST IMPORTANT TRANSLATIONAL LUNG CANCER RESEARCH IN THE NATION. ABOH RECEIVES ITS RESEARCH SUPPORT MOSTLY FROM INDIVIDUAL DONORS AND FAMILIES WHO ARE LIVING WITH LUNG CANCER OR HAVE ENDURED THE LOSS OF A LOVED ONE TO LUNG CANCER.
WHITE RIBBON AWARENESS PROGRAM (WRAP): BETWEEN 70-80,000 NONSMOKING AMERICANS DIE EACH YEAR. APPROXIMATELY 20% OF ALL CANCER DEATHS HAPPEN TO NEVER-SMOKERS (DEFINED AS HAVING SMOKED LESS THAN 100 CIGARETTES IN THEIR LIFETIME). DESPITE THESE PUBLISHED STATISTICS, MANY IN THE PUBLIC REALM BELIEVE THAT SMOKING IS THE ONLY CAUSE OF LUNG CANCER WHICH CAN LEAD TO MISSED SYMPTOMS AND LATE-STAGE DIAGNOSES. THERE ARE MANY CAUSES OF LUNG CANCER, FROM GENETIC PREDISPOSITION TO FAMILY HISTORY, RADON, AND ASBESTOS EXPOSURE TO AIR QUALITY IN GENERAL. APPROXIMATELY 70% OF LUNG CANCER PATIENTS ARE DIAGNOSED AT STAGE 3 OR 4 - WHEN IT IS DIFFICULT TO TREAT. ABOH REACHES 1,000,000 OR MORE PEOPLE EACH YEAR WITH LIFE-SAVING MESSAGES FOCUSED ON EARLIER DETECTION OF LUNG CANCER THROUGH BILLBOARD CAMPAIGNS, ONLINE MARKETING, SOCIAL MEDIA, PUBLIC PRESENTATIONS AND AWARENESS PROGRAM EVENTS.
PATIENT & FAMILY SUPPORT PROGRAMS: THE SMOKING STIGMA, SOCIETAL BLAME AND POOR PROGNOSIS OF LUNG CANCER LEAD TO HIGH LEVELS OF ANXIETY AND SORROW FOR THOSE WHO ARE LIVING WITH LUNG CANCER, WHETHER THEY SMOKED OR NOT. AN INFORMED, WELL-EDUCATED AND SUPPORTED PATIENT CAN PARTICIPATE IN SHARED DECISION-MAKING WITH HIS OR HER DOCTOR, AND THIS HAS BEEN SHOWN TO PRODUCE IMPROVED HEALTH OUTCOMES. ABOH IS HOSTING THE FIRST OF ITS KIND ONLINE, ANIMATED PATIENT EDUCATION PROGRAM AT WWW.YOUANDLUNGCANCER.COM, ALSO AVAILABLE IN SPANISH AT WWW.USTEDYCANCERDEPULMON.COM. THE BEAUTY OF THIS PROGRAM IS ITS ABILITY TO OVERCOME BARRIERS OF EDUCATION AND MEDICAL ILLITERACY TO EDUCATE LUNG CANCER PATIENTS AND THEIR FAMILY MEMBERS - NO MATTER THEIR LEARNING STYLE. ANOTHER COMPONENT OF ABOH'S SUPPORT PROGRAMS IS ITS AMBASSADOR PROGRAM, WHICH PROVIDES TRANSPORTATION, COMPANIONSHIP VISITS, AND SUPPORT GROUPS FOR PATIENTS, AS WELL AS AN ANNUAL PATIENT SUMMIT WITH HIGH-LEVEL EDUCATION DIRECTED AT PATIENTS AND CAREGIVERS LIVING WITH LUNG CANCER. ABOH IS ALSO HOSTING A LOCAL, QUARTERLY GRIEF GROUP FOR FAMILIES WHO HAVE LOST A LOVED ONE TO LUNG CANCER.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Nancy Torrison Executive Director | Officer | 50 | $127,791 |
Sue Huff Treasurer | OfficerTrustee | 1 | $0 |
Teri Kast Secretary | OfficerTrustee | 0.5 | $0 |
Gary Brausen Vice Chair | OfficerTrustee | 1 | $0 |
Randy Hertog Chair | OfficerTrustee | 2.5 | $0 |
Justin Ballsrud Board Member | Trustee | 0.5 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $167,844 |
| Related organizations | $0 |
| Government grants | $64,727 |
| All other contributions, gifts, grants, and similar amounts not included above | $909,921 |
| Noncash contributions included in lines 1a–1f | $27,459 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $1,142,492 |
| Total Program Service Revenue | $68,588 |
| Investment income | $70 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | -$17,441 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $247 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $1,194,306 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $150,000 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $122,000 |
| Compensation of current officers, directors, key employees. | $12,200 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $282,866 |
| Pension plan accruals and contributions | $5,715 |
| Other employee benefits | $14,750 |
| Payroll taxes | $36,981 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $7,952 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $89,193 |
| Advertising and promotion | $9,949 |
| Office expenses | $35,688 |
| Information technology | $6,118 |
| Royalties | $0 |
| Occupancy | $63,340 |
| Travel | $2,707 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $5,380 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $70,237 |
| Insurance | $4,319 |
| All other expenses | $0 |
| Total functional expenses | $932,955 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $318,746 |
| Savings and temporary cash investments | $372,454 |
| Pledges and grants receivable | $234,293 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $3,508 |
| Prepaid expenses and deferred charges | $22,764 |
| Net Land, buildings, and equipment | $196,449 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $1,950 |
| Total assets | $1,150,164 |
| Accounts payable and accrued expenses | $5,701 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $22,349 |
| Total liabilities | $28,050 |
| Net assets without donor restrictions | $730,012 |
| Net assets with donor restrictions | $392,102 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $1,150,164 |
Grants Awarded
Over the last fiscal year, A Breath Of Hope Lung Foundation has awarded $300,000 in support to 4 organizations.
| Grant Recipient | Amount |
|---|---|
WHITEHEAD INSTITUTE OF BIOMEDICAL RESEARCH PURPOSE: This research project focuses on improving lung cancer outcomes with two aims: 1) To determine the mechanism by which macrophage activation enhances the response to EGFR TKIs; and 2: To investigate the anti-tumor efficacy of EGFR TKIs in combination with macrophage-directed therapies in xenograft models. | $75,000 |
WHITEHEAD INSTITUTE OF BIOMEDICAL RESEARCH PURPOSE: This research project focuses on improving lung cancer outcomes with two aims: 1) To determine the mechanism by which macrophage activation enhances the response to EGFR TKIs; and 2: To investigate the anti-tumor efficacy of EGFR TKIs in combination with macrophage-directed therapies in xenograft models. | $75,000 |
UNIVERSITY OF TEXAS SOUTHWESTERN PURPOSE: The research project is seeking to understand the role of Telmerase that is expressed by most human cancers, particularly small cell lung cancer. We will target an essential survival mechanism of tumor cells to activate protective antitumor immunity and immune memory. We hypothesize that sytosolic DNA resulting from targeting telmerase with 6TdG treatment induces the cGAS/STING pathway, leading to enhanced antigen presentation and cyokine expression from tumors and dendritic cells (DC), causing the expansion and activation of tumor-specific T cells. If successful, our studies will guide the design of clinical trials. Given that NIH considers SCLC a recalcitrant disease, we believe SCLCs can easily be prioritized to be one of the first cancers to test 6TdG as these tumors do not have effective treatments currently. If we can generate strong preclinical evidence with this proposal, 6TdG can rapidly move in this subset in the clinic. | $75,000 |
UNIVERSITY OF TEXAS SOUTHWESTERN PURPOSE: The research project is seeking to understand the role of Telmerase that is expressed by most human cancers, particularly small cell lung cancer. We will target an essential survival mechanism of tumor cells to activate protective antitumor immunity and immune memory. We hypothesize that sytosolic DNA resulting from targeting telmerase with 6TdG treatment induces the cGAS/STING pathway, leading to enhanced antigen presentation and cyokine expression from tumors and dendritic cells (DC), causing the expansion and activation of tumor-specific T cells. If successful, our studies will guide the design of clinical trials. Given that NIH considers SCLC a recalcitrant disease, we believe SCLCs can easily be prioritized to be one of the first cancers to test 6TdG as these tumors do not have effective treatments currently. If we can generate strong preclinical evidence with this proposal, 6TdG can rapidly move in this subset in the clinic. | $75,000 |
Grants Recieved
Over the last fiscal year, we have identified 18 grants that A Breath Of Hope Lung Foundation has recieved totaling $139,118.
| Awarding Organization | Amount |
|---|---|
American Endowment Foundation Hudson, OH PURPOSE: DISEASE/DISORDER | $50,000 |
The Richard M Schulze Family Foundation Minneapolis, MN PURPOSE: HUMAN SERVICES | $40,000 |
Schwab Charitable Fund San Francisco, CA PURPOSE: HEALTH | $10,450 |
Saint Paul & Minnesota Foundation Saint Paul, MN PURPOSE: MULTIPLE GRANTS FOR MULTIPLE PURPOSES | $10,000 |
American Online Giving Foundation Inc Newark, DE PURPOSE: GENERAL SUPPORT | $8,720 |
Impactassets Inc Bethesda, MD PURPOSE: GENERAL SUPPORT | $6,800 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Fairwaycares Inc Madison, WI | $4,640,276 | $2,059,491 |
Lung Cancer Foundation Of America New Ulm, MN | $1,303,793 | $1,298,335 |
Steve Rummler Hope Network St Paul, MN | $635,822 | $1,043,933 |
A Breath Of Hope Lung Foundation Wayzata, MN | $1,150,164 | $1,194,306 |
Team Phenomenal Hope Inc Beloit, WI | $556,543 | $565,493 |
This Time Tomorrow Inc Menomonee Falls, WI | $505,570 | $385,797 |
Paul's Pals Inc Minnetonka, MN | $35,106 | $238,734 |
Minnesota Colorectal Cancer Research Foundation St Paul, MN | $289,500 | $294,589 |
Toris Angels Foundation Panora, IA | $712,963 | $393,136 |
Spierings Cancer Foundation Appleton, WI | $391,482 | $295,616 |
Foundation Of The Minnesota Medical Association Minneapolis, MN | $1,930,800 | $303,546 |
Shoot For Cooper Inc Reedsville, WI | $46,017 | $0 |